Drug intelligence / Profile preview

Azelaic acid

Development stage
Approved
Lead developer
Bayer
Modality
Small Molecules
Administration
Topical
01

Overview

Azelaic acid is a naturally occurring saturated dicarboxylic acid found in wheat, rye, barley, and produced by the skin yeast *Malassezia furfur*. It is used topically as a cream (typically 20%) or gel/foam (typically 15%) for the treatment of mild to moderate acne vulgaris and rosacea. Azelaic acid works through multiple mechanisms including antibacterial activity against *Propionibacterium acnes* by inhibiting bacterial protein and DNA synthesis (notably via inhibition of thioredoxin reductase), anti-inflammatory effects by reducing reactive oxygen species from neutrophils and interfering with inflammatory cytokine expression, normalization of keratinization to prevent comedone formation, and inhibition of tyrosinase which reduces melanin production—making it useful for hyperpigmentation disorders such as melasma. It also has antioxidant properties[1][3][5][6].

Brand names
AzelexFinaceaFinacea Plus
Other names
nonanedioic acidAzA
02

Targets

TYR (Tyrosinase)TXNRD2 (Thioredoxin reductase 2)

Beyond the preview

Go deeper on Azelaic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Azelaic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call